On this page
- TL;DR
- Sarcoidosis VA rating criteria (DC 6846)
- Rating sarcoidosis by lung function or by the organs involved
- Is sarcoidosis presumptive? The PACT Act and the one-year rule
- How to prove sarcoidosis is service connected without a presumption
- What your sarcoidosis records and C&P exam should show
- Why VA denies sarcoidosis claims
- Questions veterans ask about sarcoidosis
- Bottom Line
- Sources and limits
Sarcoidosis is a multi-system inflammatory disease, and the VA schedule reflects that. Diagnostic Code 6846 in 38 CFR § 4.97 rates pulmonary disease mainly through corticosteroid requirements and severe cardiopulmonary findings. The same code also allows VA to rate active disease or residuals as chronic bronchitis and to evaluate extra-pulmonary involvement under the affected body system.
Service connection is a separate question. Sarcoidosis is specifically listed in 38 U.S.C. § 1120 as presumptive for a covered veteran as defined in § 1119. It is also on VA's list of chronic diseases, which carries a separate one-year presumption. A presumption can establish the connection to service; it does not choose the percentage.
This page covers the sarcoidosis rating criteria, rating by lung function or by the other organs involved, the PACT Act and one-year presumptions, direct service connection, what your records and C&P exam should show, and why VA denies sarcoidosis claims.
TL;DR
- Sarcoidosis is DC 6846, with listed levels of 0, 30, 60, and 100 percent.
- 0%: chronic hilar adenopathy or stable lung infiltrates without symptoms or physiologic impairment.
- 30%: pulmonary involvement with persistent symptoms requiring chronic low-dose maintenance or intermittent corticosteroids.
- 60%: pulmonary involvement requiring systemic high-dose therapeutic corticosteroids for control.
- 100%: cor pulmonale, cardiac involvement with congestive heart failure, or progressive pulmonary disease with fever, night sweats, and weight loss despite treatment.
- VA may instead rate active disease or residuals as chronic bronchitis under DC 6600 and evaluate extra-pulmonary involvement under the affected body system.
- Sarcoidosis is a PACT Act presumptive disease for veterans who satisfy the statutory covered-service definition. It is also a chronic disease under 38 CFR § 3.309(a), presumed service connected if it reached 10 percent or more within one year of separation.
- Across 843 decided Board rulings on sarcoidosis from 2021 to 2026, 26.2% were granted, 23.1% denied and 50.7% remanded. That grant rate is 1.5 points above the Board-wide 24.7 percent.
Sarcoidosis VA rating criteria (DC 6846)
0 percent
The noncompensable level applies to chronic hilar adenopathy or stable lung infiltrates without symptoms or physiologic impairment. Imaging alone can establish disease without establishing a compensable level.
30 percent
The 30-percent level requires pulmonary involvement with persistent symptoms requiring chronic low-dose maintenance corticosteroids or intermittent corticosteroids. The treatment record should identify the drug, dose, frequency, and reason it is being used.
60 percent
The 60-percent level requires pulmonary involvement controlled with systemic high-dose therapeutic corticosteroids. “High dose” is a medical and record-specific question; a medication name without dosage and treatment context leaves the criterion unresolved.
100 percent
The highest level applies with cor pulmonale; cardiac involvement with congestive heart failure; or progressive pulmonary disease accompanied by fever, night sweats, and weight loss despite treatment. The code requires the complete severe pattern, not one constitutional symptom in isolation.
Rating sarcoidosis by lung function or by the organs involved
DC 6846 permits active disease or residuals to be rated as chronic bronchitis under DC 6600. That route uses pulmonary-function and other respiratory criteria. It can matter when physiologic impairment describes the disability better than the corticosteroid ladder.
Sarcoidosis can also involve the eyes, skin, heart, nervous system, liver, joints, and other organs. Outside the chest, skin lesions, eye inflammation (uveitis), liver or spleen involvement, and joint inflammation are among the most common sites, while heart and nervous system involvement is less common. DC 6846 directs extra-pulmonary involvement to the specific body system involved. The record should identify each diagnosed manifestation and distinguish it from symptoms that have another cause.
VA's anti-pyramiding rule still applies. Separate ratings require distinct manifestations, not different labels for the same respiratory impairment. Under 38 CFR § 4.96(a), DC 6846 is also one of the respiratory codes that are not combined with each other. If you have sarcoidosis and another lung diagnosis such as COPD, VA assigns one respiratory rating under the code for the predominant disability, raised one level if the overall disability warrants it.
Is sarcoidosis presumptive? The PACT Act and the one-year rule
Sarcoidosis has two separate presumptions. Either one can establish the connection to service without a medical opinion linking the disease to service.
PACT Act sarcoidosis presumption (38 U.S.C. § 1120)
Section 1120 lists sarcoidosis as presumptively service connected when it becomes manifest in a “covered veteran.” The same section separately lists granulomatous disease, the wider group of diseases that sarcoidosis belongs to. Section 1119 defines covered service through specified locations and periods. This is more precise than saying that any burn-pit exposure or any deployment qualifies.
You are a covered veteran if you served while assigned to a duty station in one of these places, including the airspace above it.
- Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, Somalia, or the United Arab Emirates, on or after August 2, 1990.
- Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen, or Uzbekistan, or another country VA determines is relevant, on or after September 11, 2001.
Section 1120 sets no time limit for when the disease appears after service. It is a statutory presumption; 38 CFR § 3.320, VA's particulate-matter regulation, does not list sarcoidosis. VA can still rebut the presumption with affirmative evidence against it, such as a recognized cause that occurred after separation (38 U.S.C. § 1113).
For the presumptive route, submit the following.
- service records establishing a qualifying location and period;
- a current sarcoidosis diagnosis; and
- records showing the current manifestations and treatment.
The presumption addresses nexus. VA still needs evidence to assign the percentage and any organ-specific evaluations.
The one-year chronic disease presumption (38 CFR § 3.309(a))
Sarcoidosis is also on the list of chronic diseases in 38 CFR § 3.309(a). Under 38 CFR § 3.307, it is presumed service connected if you served 90 days or more during a war period or after December 31, 1946, and it became manifest to a degree of 10 percent or more within one year after separation. This route does not depend on where you served. It does depend on records from that first year showing the disease and how severe it was.
Under 38 CFR § 3.303(b), once a chronic disease is shown in service or within that year, later flares of the same disease are service connected unless they are clearly due to another cause.
How to prove sarcoidosis is service connected without a presumption
Veterans outside both presumptions can still pursue direct service connection under 38 CFR § 3.303. That route requires a current diagnosis, an in-service event or onset, and a medical opinion linking the disease to service.
If you have evidence of a toxic exposure risk activity in service, such as an entry in an exposure tracking record, 38 U.S.C. § 1168 requires VA to provide an exam and get a medical opinion on whether your sarcoidosis is at least as likely as not linked to that exposure, unless VA finds no indication of an association. The examiner must consider your total exposure across all deployments.
Research supports asking the question. A 2026 study of VA patient records found that veterans whose military jobs involved inorganic dust exposure had a modestly higher risk of sarcoidosis, with the risk highest two to five years after separation. A link across a population is not proof for one veteran, so the claim still needs an opinion that applies the evidence to your service, your job, and your timeline.
What your sarcoidosis records and C&P exam should show
- How the diagnosis was established and what alternative infections or diseases were excluded.
- Chest imaging and pulmonary-function studies.
- Corticosteroid name, dose, schedule, duration, and treatment purpose.
- Whether disease is stable, active, or progressive despite treatment.
- Cardiology evidence for cor pulmonale, cardiac sarcoidosis, or heart failure.
- Diagnosed eye, skin, neurologic, or other extra-pulmonary involvement.
- Functional effects such as exertional limitation tied to objective disease.
At the C&P exam, describe the steroid treatment you have actually had: the drug, the dose, how long you took it, and whether it was a maintenance dose or a higher dose to bring the disease under control. That distinction is the line between 30 and 60 percent.
Why VA denies sarcoidosis claims
Across 843 decided Board rulings on sarcoidosis from 2021 to 2026, 26.2% were granted, 23.1% denied and 50.7% remanded. That grant rate is 1.5 points above the Board-wide 24.7 percent, measured over 1,239,429 decided rulings. A remand was the most common outcome for sarcoidosis.
Too few sarcoidosis service connection claims were denied for a reliable breakdown of denial reasons, so the list below is a set of evidence checks, not a ranking of observed Board denials.
No proof of covered service. The PACT Act presumption needs service records placing you at a duty station in a covered location during the covered period. A general statement that you deployed is not enough.
No medical link outside the presumptions. For a direct claim, a missing opinion, or one that does not explain how your exposure or service relates to the disease, leaves the nexus element unproven.
Steroid use without dose and purpose. Saying “steroids” without documenting the systemic dose and duration leaves the 30 versus 60 percent question open.
Treating the presumption as a percentage. The PACT Act presumption decides service connection, not the rating.
Organ involvement ignored or counted twice. Diagnosed eye, skin, or heart involvement that nobody claims is not rated. The same pulmonary impairment cannot be counted under both DC 6846 and DC 6600.
Symptoms attributed without medical support. Describing all fatigue or joint pain as sarcoidosis without medical attribution invites a finding that those symptoms have another cause.
When the Board sends a sarcoidosis claim back instead of deciding it, the most common reason is an inadequate VA exam or opinion, followed by records VA still has to get. In the Board's service connection rulings, claims argued under a presumption were granted somewhat more often than direct claims, and secondary claims were seldom granted. Rating appeals fared about as well as service connection claims. The Board section below shows the remand reasons, what happened after a remand, and both comparisons.
Questions veterans ask about sarcoidosis
Is sarcoidosis a presumptive condition for VA?
Yes, in two ways. Under the PACT Act, 38 U.S.C. § 1120 presumes sarcoidosis is service connected for a covered veteran, meaning one who served at a duty station in listed countries such as Iraq, Kuwait, or Afghanistan during the covered periods. Separately, 38 CFR § 3.309(a) lists sarcoidosis as a chronic disease, presumed service connected if it reached 10 percent or more within one year of separation after 90 days or more of qualifying service.
What is the highest VA rating for sarcoidosis?
100 percent under DC 6846, for cor pulmonale, cardiac involvement with congestive heart failure, or progressive lung disease with fever, night sweats, and weight loss despite treatment. Diagnosed involvement of other organs, such as the eyes or skin, is rated under those body systems, so your combined rating can include more than the lung rating.
Does prednisone get a 30 or 60 percent sarcoidosis rating?
DC 6846 does not set a milligram cutoff. It assigns 30 percent for persistent lung symptoms requiring chronic low-dose maintenance or intermittent corticosteroids, and 60 percent when systemic high-dose therapeutic corticosteroids are required to control the disease. Your prescribing records should say whether the dose is a maintenance dose or a dose to control active disease.
Can sarcoidosis in the eyes, skin, or heart be rated separately?
Yes, when it is diagnosed. DC 6846 directs VA to rate extra-pulmonary involvement under the body system involved, so eye, skin, or heart involvement is evaluated under those systems' codes. VA still cannot rate the same symptom twice under 38 CFR § 4.14.
Will VA order an exam for sarcoidosis from burn pit exposure?
If you served in a PACT Act covered location, the presumption already covers the link to service, and the exam is about severity. If you did not, but you have evidence of sarcoidosis and of a toxic exposure risk activity in service, 38 U.S.C. § 1168 requires VA to provide an exam and a medical opinion on whether the two are at least as likely as not linked, unless VA finds no indication of an association.
Bottom Line
Sarcoidosis claims have two maps. Section 1120 may establish presumptive service connection for a covered veteran, and § 3.309(a) can do the same when the disease reached a compensable level within a year of separation. DC 6846 then rates pulmonary severity by treatment and severe findings, while permitting chronic-bronchitis or organ-specific routes when those better describe the residuals. A complete packet proves both the qualifying service and the current medical pattern.
Sources and limits
Legal sources: 38 CFR § 4.97, 38 CFR § 4.96, 38 U.S.C. § 1119, 38 U.S.C. § 1120, 38 U.S.C. §§ 1113 and 1168, 38 CFR §§ 3.307, 3.309 and 3.320, and 38 CFR § 3.303, checked October 6, 2026.
Medical sources: the organ involvement pattern is from Sève, "Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis," Cells (2021). The dust exposure finding is from Seedahmed, "Sarcoidosis risk among U.S. Veterans exposed to inorganic dust during military service," Annals of the American Thoracic Society (2026), a case-control study of VA patient records.
Board figures come from Claim Raven's read of 510,968 Board decisions from 2021 to 2026, which contain 1,376,193 rulings; dismissed, withdrawn and moot rulings are excluded from the shares. These are appealed claims, not your personal odds.
